GO can increase the ROS level in tumor cells under near-infrared light irradiation. Mth1 inhibitors can improve the efficacy of Chemo-PDT by inhibiting Mth1 protein and improving the sensitivity of cells to ROS, and promote cell apoptosis and autophagy. Here, NUDT1 is linked to neoplasm.